Portfolio Management Service

Divi’s Laboratories Limited

Highlights :

  • The top line of the Company has consistently been improving registering a CAGR of 23.70% over the last five years.
  • 42 patents processed till 2022 with an R&D team of ~ 400 members.
  • Return on Net Worth is 25% in FY2022 as compared to 21% in FY2021.


Leave a Comment

Your email address will not be published. Required fields are marked *

Request Download Link

Open chat
Hello Investors!